BSE filing, NSE: SUMICHEM. Summary written from the filing by ALFA Finder's alert engine.
Sumitomo Chemical India Ltd: key numbers
- Share price
- ₹335.45
- Market cap
- ₹16,744 Cr
- Revenue (annual)
- ₹3,238 Cr
- Net profit (annual)
- ₹543.0 Cr
- P/E (TTM)
- 30.0×Sector 34.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sumitomo Chemical India Ltd
All →Sumitomo Chemical India Earnings Call Transcript: Key Takeaways
Sumitomo Chemical delivered stable H1 performance despite India's fourth weakest monsoon since 2001. Management maintained 20%+ EBITDA margins through cost control and a 22% value growth in specialty products, offsetting volume declines in generic segments.
Sumitomo Chemical India Investor Presentation: Key Takeaways
Q2FY27 revenue Rs907 Cr (-2% YoY), PAT Rs157 Cr (-11%), EBITDA margin 20.5% (-297bps). H1FY27 PAT up 5% to Rs372 Cr on revenue down 1%. Volume-led weakness; inventory cost mismatch hit margins.
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹167.4 Cr, Down 5.8% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹167.4 Cr (-5.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹167.4 Cr · -5.8% YoY
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹157.4 Cr, Down 11.5% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹157.4 Cr (-11.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹157.4 Cr · -11.5% YoY
Sumitomo Chemical India Board Meeting Date
Sumitomo Chemical India Limited has scheduled a board meeting for October 26, 2026, to approve the standalone and consolidated financial results for the period ended September 2026.
Sumitomo Chemical India Investor Presentation: Key Takeaways
Sumitomo Chemical reported resilient Q1FY27 results despite a difficult domestic operating environment. Revenue grew 1% to ₹1,063 cr, while Net Profit surged 20% to ₹215 cr, aided by an insurance claim.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.